Published in Circulation on November 01, 1973
A controlled trial of community based coronary rehabilitation. Br Heart J (1990) 1.13
Influence of beta adrenergic blockade on effects of physical training in patients with ischaemic heart disease. Br Heart J (1982) 0.86
Maximal exercise testing in patients with spontaneous angina pectoris associated with transiet ST segment elevation. Risks and electrocardiographic findings. Br Heart J (1975) 0.81
Haemodynamics during maximal exercise after coronary bypass surgery. Br Heart J (1978) 0.77
Effects of a cardioselective beta 1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction. Am J Cardiol (1983) 2.10
Histiocytosis X histogenetic arguments for a Langerhans cell origin. Biomedicine (1973) 1.90
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation (1992) 1.65
Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation. Eur J Clin Invest (1998) 1.60
Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study. Am J Cardiol (1991) 1.52
Coronary artery reperfusion in acute myocardial infarction: assessment by pre- and postintervention thallium-201 myocardial perfusion imaging. Am J Cardiol (1985) 1.47
Diagnostic value of history and maximal exercise electrocardiography in men and women suspected of coronary heart disease. Circulation (1977) 1.46
Effect of dexfenfluramine treatment on body weight, blood pressure and noradrenergic activity in obese hypertensive patients. Eur J Clin Pharmacol (1992) 1.45
Diastolic function of the nonfilling human left ventricle. J Am Coll Cardiol (1992) 1.41
Angiographic evaluation of vasomotor properties of internal mammary arteries before and after coronary artery bypass grafting in men. Am J Cardiol (1990) 1.39
Antianginal effects of corwin, a new beta-adrenoceptor partial agonist. Am J Cardiol (1984) 1.22
Importance of the splanchnic vascular bed in human blood pressure regulation. J Appl Physiol (1972) 1.16
Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587. Eur Heart J (1982) 1.16
Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease. Cardiovasc Drugs Ther (1994) 1.13
Impaired early left ventricular relaxation in coronary artery disease: effects of intracornary nifedipine. Circulation (1980) 1.12
Hemodynamic effects of Corwin (ICI 118,587), a new cardioselective beta-adenoceptor partial agonist. Eur Heart J (1983) 1.11
Skin and muscle components of forearm blood flow in directly heated resting man. J Appl Physiol (1972) 1.10
Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol (1993) 1.08
Coronary arteriography in acute transmural myocardial infarction. Am Heart J (1979) 1.05
Increased arteriovenous oxygen difference after physical training in coronary heart disease. Circulation (1971) 1.05
Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. J Card Fail (2000) 1.04
Haemodynamic and electrocardiographic effects of practolol during upright exercise in coronary heart disease. Cardiovasc Res (1973) 1.03
Effects of physical training on exertional S-T-segment depression in coronary heart disease. Circulation (1971) 1.03
Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial). J Am Coll Cardiol (1994) 1.00
Force-velocity-length relations in hypertrophic cardiomyopathy: evidence of normal or depressed myocardial contractility. Am J Cardiol (1983) 0.99
Hemodynamic determinants of exercise ST-segment depression in coronary patients. Circulation (1970) 0.98
Relation of exercise capacity to left ventricular systolic function and diastolic filling in idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol (1999) 0.97
Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem. J Cardiovasc Pharmacol (1992) 0.96
Diagnostic value of exercise electrocardiography and thallium myocardial scintigraphy in patients without previous myocardial infarction: a Bayesian approach. Circulation (1981) 0.91
Diagnostic value of computerized exercise testing in men without previous myocardial infarction. A multivariate, compartmental and probabilistic approach. Eur Heart J (1985) 0.90
Coronary collaterals and left ventricular function early after acute transmural myocardial infarction. Eur Heart J (1982) 0.89
Prediction of mortality following hospital discharge after thrombolysis for acute myocardial infarction: is there a need for coronary angiography? European Cooperative Study Group. Eur Heart J (1993) 0.89
Assessment of regional left ventricular relaxation in patients with coronary artery disease: importance of geometric factors and changes in wall thickness. Circulation (1984) 0.89
Alternative diagnostic strategies for coronary artery disease in women: demonstration of the usefulness and efficiency of probability analysis. Circulation (1985) 0.89
Surgical treatment of variant angina: use of plexectomy with aortocoronary bypass. Circulation (1980) 0.88
Long-term effects of xamoterol on left ventricular diastolic function and late remodeling: a study in patients with anterior myocardial infarction and single-vessel disease. Circulation (1988) 0.87
Cardiovascular effects of AR-L115 BS in conscious dogs with and without chronic congestive heart failure. J Cardiovasc Pharmacol (1982) 0.86
Patient compliance and therapeutic coverage: comparison of amlodipine and slow release nifedipine in the treatment of hypertension. The Belgian Collaborative Study Group. Eur J Clin Pharmacol (1995) 0.86
Effects of nitroglycerin on "maximal" oxygen intake and exercise electrocardiogram in coronary heart disease. Circulation (1971) 0.86
Hemodynamic effects of felodipine at rest and during exercise in exertional angina pectoris. Am J Cardiol (1983) 0.86
Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris. Am J Cardiol (1984) 0.86
Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer. Br Heart J (1991) 0.85
Changes in myocardial metabolism during therapy in patients with chronic stable angina: a comparison of long-term dosing with propranolol and nicardipine. Circulation (1986) 0.84
Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation (1994) 0.84
Effects of asynchrony on myocardial relaxation at rest and during exercise in conscious dogs. Am J Physiol (1988) 0.84
Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty. Am J Cardiol (1987) 0.83
Prolonged exercise induces left ventricular dysfunction in healthy subjects. J Appl Physiol (1985) (1991) 0.83
Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris. Am J Cardiol (1981) 0.83
Assessment of right and left ventricular volumes during upright exercise in normal men. Eur Heart J (1982) 0.83
Left ventricular sensitivity to beta-adrenoceptor-stimulating drugs in patients with ischemic heart disease and varying degrees of ventricular dysfunction. Circ Res (1987) 0.83
Cardiac mechanics during development of heart failure. SOLVD Investigators. Circulation (1993) 0.82
How accurate is dobutamine stress electrocardiography for detection of coronary artery disease? Comparison with two-dimensional echocardiography and technetium-99m methoxyl isobutyl isonitrile (mibi) perfusion scintigraphy. J Am Coll Cardiol (1994) 0.82
Inotropic drugs of the future. Eur J Clin Invest (1982) 0.82
Comparisons of the inotropic effects of the beta 1-adrenoceptor partial agonists SL 75.177.10 and ICI 118,587 with digoxin on the intact canine heart. J Cardiovasc Pharmacol (1984) 0.81
Circulating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markers. Peptides (2005) 0.81
Reassessment of the relation between QRS forces of the orthogonal electrocardiogram and left ventricular ejection fraction. Eur Heart J (1983) 0.81
[Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)]. Ann Med Interne (Paris) (1985) 0.81
Hemodynamic and cardiac effects of nicardipine in patients with coronary artery disease. J Cardiovasc Pharmacol (1984) 0.81
Diagnosis of coronary artery disease in elderly patients: safety and efficacy of dobutamine echocardiography. Eur Heart J (1993) 0.81
[The value of xamoterol in moderate ischemic cardiac insufficiency]. Ann Cardiol Angeiol (Paris) (1984) 0.81
Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease. Postgrad Med J (1984) 0.81
Effects of dobutamine and sulmazol (AR-L115 BS) on myocardial metabolism and coronary, femoral, and renal blood flows: a comparative study in normal dogs and in dogs with chronic volume overload. J Cardiovasc Pharmacol (1983) 0.81
Maximal exercise testing in patients with spontaneous angina pectoris associated with transiet ST segment elevation. Risks and electrocardiographic findings. Br Heart J (1975) 0.81
Venomotor responses to rapid changes in skin temperature in exercising man. J Appl Physiol (1971) 0.81
Regional remodeling and nonuniform changes in diastolic function in patients with left ventricular dysfunction: modification by long-term enalapril treatment. The SOLVD Investigators. J Am Coll Cardiol (1993) 0.80
Logistic discriminant analysis improves diagnostic accuracy of exercise testing for coronary artery disease in women. Circulation (1991) 0.80
Risk stratification in patients with dilated cardiomyopathy: contribution of Doppler-derived left ventricular filling. Am J Cardiol (1998) 0.80
Impaired regional diastolic distensibility in coronary artery disease: relations with dynamic left ventricular compliance. Am Heart J (1986) 0.80
Analysis of the mechanisms underlying the changes in left ventricular filling dynamics during oral nisoldipine therapy in patients with anterior myocardial infarction. Eur Heart J (1992) 0.79
Prognostic value of symptom limited exercise testing in men with a high prevalence of coronary artery disease. Eur Heart J (1985) 0.79
Effects of long-term combined dosing with nicardipine and propranolol on coronary hemodynamics, myocardial metabolism, and exercise tolerance in patients with angina pectoris: comparison with monotherapy. Am Heart J (1988) 0.79
Maximal expiratory flow rates and airway resistance following histamine aerosols in asthmatics. Scand J Respir Dis (1973) 0.79